Skip to main content
OpenTrials
Completed

NCT Number: NCT04918134

Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong Province

Helicobacter pylori can lead to a variety of digestive system diseases.The eradication of Helicobacter pylori plays an importment role for the treatment of gastrointestinal ulcer and prevention of gastric cancer .Compared with other countries and regions in the world, the infection rate of Helicobacter pylori in China can reach more than 50%. The non-standard diagnosis and treatment of Helicobacter pylori greatly reduces its eradication rate and increases its drug resistance.Therefore, it is very important to strengthen the standardization of diagnosis and treatment to improve the eradication rate.

The purpose of this study is to investigate the diagnosis and treatment status of Helicobacter pylori among gastroenterologists in general hospitals in Shandong Province.It can help us to understand the actual situation of diagnosis and treatment of Helicobacter pylori in hospitals at all levels, and to provide targeted diagnosis and treatment training for doctors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Helicobacter Pylori Infection

Sex eligibility

All sexes

Study type

Observational

Primary location

Qilu hosipital

Jinan, Shandong, 257000, China

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All the gastroenterologists in secondary and tertiary general hospitals of Shandong province

Exclusion criteria

  • A hospital that does not include gastroenterology
  • Hospitals and gastroenterologists that refuse to sign informed consent

Treatment and study plan

Primary outcomes

  1. the results of the questionnaires

    Time frame: 2 months

    the results of each question of the questionnaires

Sponsors and collaborators

Lead sponsor

Shandong University

Other

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Jun 8, 2021
Registry last updated
Oct 19, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.